Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (5)
  • 2025 (59)
  • 2024 (43)
  • 2023 (80)
  • 2022 (102)
  • 2021 (81)
  • 2020 (16)
  • 2019 (22)
  • 2018 (7)
  • 2017 (3)
  • 2003 (1)

Subject

  • Drug Trafficking (4103)
  • Synthetic drugs (1097)
  • Guns/Weapons (1009)
  • OCDETF/Task Force (817)
  • Fake Pills (669)
  • Arrests/Convictions - Major (623)
  • Guilty Plea (540)
  • Seizures (Drugs/Property) (473)
  • Overdose (324)
  • Major Law Enforcement Operation (274)
  • Diversion Division (250)
  • Take Back Day (246)
  • Task Forces/Task Force Officers (235)
  • Pharmaceuticals/Pharmacists/Physicians (226)
  • Money Laundering (207)
  • Gangs (199)
  • Outreach/Drug Prevention (185)
  • Fentanyl Awareness (158)
  • One Pill Can Kill (113)
  • HIDTA (104)
  • Press Conferences (68)
  • Narcoterrorism (54)
  • Extraditions (51)
  • Public and Media Affairs - also see Congressional Affairs (51)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Counterfeit Pills (25)
  • Fentanyl Free America (24)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Other (11)
  • Campaigns (10)
  • Intergovernmental Affairs (9)
  • Critical Incident (7)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Prescription Drugs (370)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)

Drug Name

  • Oxycodone (80)
  • Fentanyl (72)
  • Opioids (64)
  • Synthetic Opioids (29)
  • Methamphetamine (22)
  • Hydromorphone (20)
  • Benzodiazepines (14)
  • Morphine (11)
  • Amphetamines (10)
  • Cocaine (9)
  • Heroin (6)
  • Methadone (6)
  • Marijuana (Cannabis) (4)
  • Steroids (3)
  • Ketamine (2)
  • GHB (1)
  • Marijuana Concentrates (1)
  • Psilocybin (1)

Field Division

  • Washington, DC (52)
  • St. Louis (42)
  • New York (37)
  • Headquarters (30)
  • New England (25)
  • Seattle (25)
  • El Paso (20)
  • Atlanta (19)
  • Miami (19)
  • New Jersey (19)
  • Omaha (18)
  • Chicago (17)
  • Dallas (16)
  • Houston (12)
  • San Francisco (12)
  • Louisville (10)
  • New Orleans (10)
  • Los Angeles (9)
  • San Diego (9)
  • Rocky Mountain (7)
  • Phoenix (6)
  • Detroit (3)
  • Philadelphia (2)
Clear All Results
419 Results - Showing 381 to 390
PRESS RELEASE

Retired Cadott, Wisconsin physician to pay $70,000 to resolve controlled substances prescribing, recordkeeping violations

MADISON, Wis. – The Drug Enforcement Administration Special Agent in Charge Robert J. Bell of the Chicago Field Division, and the United States Attorney Scott C. Blader announced that Clifford T. Bowe, M.D., a retired Cadott, Wisconsin physician, entered into a settlement agreement to pay $70,000 to resolve civil allegations...
PRESS RELEASE

Dallas Doctor Pleads Guilty to Prescription Drug Diversion Scheme on Elderly

DALLAS - A Dallas doctor has pleaded guilty to a felony for prescription drug diversion crimes perpetrated on elderly victims, announced Eduardo A. Chavez, Special Agent in Charge of the DEA Dallas Field Division and U.S. Attorney Erin Nealy Cox. Dr. Edward Agura, 63, pleaded guilty before U.S. Magistrate Judge...
PRESS RELEASE

Three doctors indicted for conspiring to distribute oxycodone

ST. LOUIS – Eleven individuals were indicted today by a federal grand jury for conspiracy to distribute controlled medications, such as oxycodone, without a legitimate medical purpose, obtaining controlled medication by deceit and subterfuge, paying and receiving illegal kickbacks for referrals to lab for urine tests of the patients, and...
PRESS RELEASE

St. Louis County dentist sentenced to 18 months after issuing illegal prescriptions for opioid narcotic drugs

ST. LOUIS – Bradley A. Seyer, D.D.S., 53, of Florissant, Missouri, was sentenced today to 18 months of imprisonment and a $50,000 fine. Previously, on June 26, 2019, Dr. Seyer pleaded guilty to two felony charges of making false statements to Medicare and illegally issuing prescriptions for narcotic opioid drugs...
PRESS RELEASE

DEA releases strategic planning guide to prevent drug use among college students

WASHINGTON – The U.S. Drug Enforcement Administration today released Prevention with Purpose: A Strategic Planning Guide for Preventing Drug Misuse Among College Students. This new publication provides a road map for college and university-based prevention professionals to address campus-wide drug misuse issues. “With vaping, marijuana use, and the abuse of...
PRESS RELEASE

Pain management doctor pleads guilty to conspiracy to distribute controlled substances and health care fraud

BUFFALO, N.Y. – U.S. Attorney James P. Kennedy, Jr. and U.S. Drug Enforcement Administration New York Division Special Agent in Charge Ray Donovan announced today that Dr. Eugene Gosy, 59, of Clarence, N.Y., pleaded guilty before Chief U.S. District Judge Frank P. Geraci, Jr. to conspiracy to distribute controlled substances...
PRESS RELEASE

Federal grand jury adds two new charges resulting in death against Carrizo Springs doctor

SAN ANTONIO - In Del Rio, a federal grand jury added two new charges of distribution of a controlled substance resulting in death to an existing 20-count indictment returned in May against Dr. Alfonso Luevano, announced DEA Houston Division Special Agent in Charge Will Glaspy, U.S. Attorney John F. Bash...
PRESS RELEASE

Overprescribing opioids costs La Jolla doctor $125,000

SAN DIEGO – Dr. Roger A. Kasendorf, an osteopathic physician practicing in La Jolla, agreed to pay $125,000 to resolve allegations that he illegally prescribed opioids to his patients. The highly addictive and frequently abused opioids he prescribed included fentanyl, hydromorphone, oxymorphone, and oxycodone. In response to the Justice Department’s...
PRESS RELEASE

Five defendants, including two medical doctors, charged as part of Northeast Regional Health Care Fraud Takedown

BROOKLYN, NY - Four individuals, including two doctors, a pharmacist who had previously lost his license and been excluded from participating in the Medicaid and Medicare programs and a pharmacy owner have been charged for their participation in schemes in which the Medicare and Medicaid programs were fraudulently billed more...
PRESS RELEASE

DEA announces “360 Strategy” in the SouthCoast region of Massachusetts to address fentanyl, heroin, prescription drugs and violent crime

BOSTON – DEA New England Division Special Agent in Charge Brian D. Boyle announced today that the SouthCoast region of Massachusetts will be the second location in the Northeast to initiate a comprehensive diversion control, law enforcement and prevention “360 Strategy” to help cities dealing with the fentanyl, heroin and...

Pagination

  • First page «
  • Previous
  • Page 34
  • Page 35
  • Page 36
  • Page 37
  • Page 38
  • Current page 39
  • Page 40
  • Page 41
  • Page 42
  • Next
  • Last page »
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster